| Metabolic signature of obesity-associated insulin resistance and type 2 diabetes H Al-Sulaiti, I Diboun, MV Agha, FFS Mohamed, S Atkin, AS Dömling, ... Journal of translational medicine 17, 1-11, 2019 | 126 | 2019 |
| Triglyceride profiling in adipose tissues from obese insulin sensitive, insulin resistant and type 2 diabetes mellitus individuals H Al-Sulaiti, I Diboun, S Banu, M Al-Emadi, P Amani, TM Harvey, ... Journal of translational medicine 16 (1), 1-13, 2018 | 66 | 2018 |
| Association of polybrominated diphenyl ethers in two fat compartments with increased risk of insulin resistance in obese individuals M Helaleh, I Diboun, N Al-Tamimi, H Al-Sulaiti, M Al-Emadi, A Madani, ... Chemosphere 209, 268-276, 2018 | 35 | 2018 |
| Mediators of Impaired Adipogenesis in Obesity-Associated Insulin Resistance and T2DM H Al-Sulaiti, AS Dömling, MA Elrayess Adipose Tissue—An Update, 2019 | 12 | 2019 |
| Studies on vascular response to full superantigens and superantigen derived peptides: Possible production of novel superantigen variants with less vasodilation effect for … SS Bashraheel, AD AlQahtani, FB Rashidi, H Al-Sulaiti, A Domling, ... Biomedicine & Pharmacotherapy 115, 108905, 2019 | 8 | 2019 |
| Metabolomics approaches for the diagnosis, treatment, and better disease management of viral infections H Al-Sulaiti, J Almaliti, CB Naman, AA Al Thani, HM Yassine Metabolites 13 (8), 948, 2023 | 4 | 2023 |
| Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens S Thomas, MK Smatti, H Alsulaiti, HT Zedan, AH Eid, AA Hssain, ... Journal of Medical Virology 96 (5), e29628, 2024 | 1 | 2024 |
| Comparing the metabolic signatures of obesity defined by waist circumference, waist‐hip ratio, or BMI M Al Hariri, H Al‐Sulaiti, N Anwardeen, K Naja, M A. Elrayess Obesity, 2024 | | 2024 |
